Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$104.82 USD

104.82
5,933,554

+1.86 (1.81%)

Updated May 22, 2024 04:02 PM ET

After-Market: $104.81 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (144 out of 249)

Industry: Medical - Products

Better trading starts here.

Zacks News

Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?

Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Here's Why You Should Hold on to Abbott (ABT) Stock for Now

Abbott's (ABT) share recovery in the Nutrition business buoys optimism.

The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants

UnitedHealth, Danaher, Abbott and Ark Restaurants are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for UnitedHealth, Danaher & Abbott

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).

Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips

Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips are included in this Analyst Blog.

Sheraz Mian headshot

Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix

Today's Research Daily features the Q1 earnings season scorecard and updated analyst reports on Tesla (TSLA), JNJ (JNJ), Netflix (NFLX) and others.

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

PBH vs. ABT: Which Stock Is the Better Value Option?

PBH vs. ABT: Which Stock Is the Better Value Option?

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

Smart Beta ETF report for NOBL

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Q1 Earnings Review

Q1 Earnings Review

Mark Vickery headshot

Markets Try to Shake Off April Blues

Late March highs -- including all-time S&P levels -- have given way to profit-taking and existential concerns.

Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.

Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Abbott (ABT) Tops Q1 Earnings and Revenue Estimates

Abbott (ABT) delivered earnings and revenue surprises of 2.08% and 1.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Markets Mixed as Q1 Earnings, Powell Control News Headlines

Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).

Shaun Pruitt headshot

3 Buy Rated Stocks to Consider as Earnings Approach

Several top-rated Zacks stocks are standing out before their first-quarter earnings report next week and here are three to consider.

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.

Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Evaluate the expected performance of Abbott (ABT) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.

Abbott (ABT) Rises Higher Than Market: Key Facts

The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.

HAE vs. ABT: Which Stock Is the Better Value Option?

HAE vs. ABT: Which Stock Is the Better Value Option?

Abbott (ABT) Faces Low Testing Demand, Currency Headwinds

Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.